Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to investigate the safety and tolerability of AIR001 Inhalation Solution when administered under conditions of hypoxia and to identify dose levels of drug resulting in a reduction in pulmonary arterial pressure under these hypoxic conditions.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Aires Pharmaceuticals, Inc.
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Normal male and female volunteers

• Age 18-55

• Demonstrate a rise in pulmonary artery pressure to low inspired oxygen concentration (a normal response to breathing a low level of oxygen)

Exclusion Criteria:

• Significant medical illnesses

• Risk factors for pulmonary hypertension

• G6PD or Cytochrome B5 Reductase deficiencies

• History of any form of altitude sickness

• Current prescription or over the counter medication use